The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in more than 90%…
I have always been interested in the idea of food as medicine, and the significant role our diets play in our long-term health. On the latest episode of “Healthful,” I sat down with Dr. Laura Cox, an assistant professor at Brigham and Women’s Hospital and Harvard Medical School. Cox is an expert on the gut…
On this “Face the Nation with Margaret Brennan” broadcast, moderated by Margaret Brennan: Neel Kashkari, Minneapolis Fed president and CEO Dr. Mehmet Oz, Centers for Medicare & Medicaid Services administrator Dr. Scott Gottlieb, former FDA commissioner Rep. Byron Donalds, Republican of Florida and candidate for governor Rep. Seth Moulton, Democrat of Massachusetts and…
The following is the transcript of the interview with former FDA Commissioner Scott Gottlieb, who is on the boards of Pfizer and UnitedHealthCare, that aired on “Face the Nation with Margaret Brennan” on Aug. 23, 2026. MARGARET BRENNAN: We turn now to former FDA Commissioner Dr. Scott Gottlieb. He sits on the boards of Pfizer…
A Food and Drug Administration advisory panel voted to broaden access to at least one peptide during a two-day meeting discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes during a surge of interest in the unapproved therapies. Peptides are short strings of amino acids, the building blocks of proteins, linked by…
